Version 5.4
Bos taurus Protein: SUMF2
Summary
InnateDB Protein IDBP-691900.2
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol SUMF2
Protein Name Sulfatase-modifying factor 2
Synonyms
Species Bos taurus
Ensembl Protein ENSBTAP00000010773
InnateDB Gene IDBG-639713 (SUMF2)
Protein Structure
UniProt Annotation
Function Lacks formyl-glycine generating activity and is unable to convert newly synthesized inactive sulfatases to their active form. Inhibits the activation of sulfatases by SUMF1 (By similarity). {ECO:0000250}.
Subcellular Localization Endoplasmic reticulum lumen {ECO:0000250}.
Disease Associations
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
They are also associated with 4 interaction(s) predicted by orthology.
Predicted by orthology
Total 4 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0005515 protein binding
GO:0042803 protein homodimerization activity
GO:0046872 metal ion binding
Biological Process
Cellular Component
GO:0005783 endoplasmic reticulum
GO:0005788 endoplasmic reticulum lumen
Protein Structure and Domains
PDB ID
InterPro IPR005532 Formylglycine-generating sulphatase enzyme domain
IPR016187 C-type lectin fold
PFAM PF03781
PRINTS
PIRSF
SMART
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt Q58CP2
PhosphoSite PhosphoSite-
TrEMBL
UniProt Splice Variant
Entrez Gene 509497
UniGene Bt.2897
RefSeq NP_001014881
HUGO
OMIM
CCDS
HPRD
IMGT
EMBL BC149259 BT021905
GenPept AAI49260 AAX46752

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca